France – April 2, 2025.SurgiMab is proud to announce that it has been awarded the Tech for Future 2025 prize in Healthcare by La Tribune
This prestigious award follows a national innovation tour and rigorous evaluation by a panel of expert jurors. SurgiMab was recognized for its pioneering work in fluorescence-guided oncology, a breakthrough technology designed to enhance tumor detection and reduce cancer recurrence rates.
The award highlights SurgiMab’s commitment to transforming cancer surgery outcomes through innovation in precision imaging.
The ceremony took place on April 2, 2025, in Paris, and was featured in both the regional and national editions of La Tribune, reflecting the company’s scientific excellence and technological leadership.
Read the full article here : https://www.latribune.fr/technos-medias/surgimab-ou-la-revolution-de-la-fluorescence-pour-eliminer-les-cancers-1021498.html
For more information or to arrange a meeting, please contact Françoise Cailler at: fcailler@surgimab.com
